Connect with others who understand.

  •   Learn from expert-reviewed resources
  •   Real advice from people who’ve been there
  •   People who understand what you’re going through
Sign Up Log In
Powered By

Sickle Cell Gene Therapy: Cost, Coverage, and Getting Access

Medically reviewed by Warren Brenner, M.D.
Written by Rashida Ruwa
Posted on October 19, 2026

Key Takeaways

  • Sickle cell gene therapy can cost millions of dollars, and navigating insurance coverage, eligibility, and treatment access can feel overwhelming for many people with the condition.
  • Two gene therapies, Casgevy and Lyfgenia, are approved in the United States for sickle cell disease, with list prices of 2.2 million and 3.1 million dollars respectively, though what a person actually pays depends on their insurance plan, location, and eligibility. Beyond the therapy itself, costs can include testing, hospitalization, travel, fertility preservation, and years of follow-up care.
  • Talking with a hematologist is a good first step to learning about eligibility, referrals, and insurance requirements, and asking for a patient navigator or financial counselor early in the process can help with paperwork, financial assistance, and planning for time away from home.
  • View all takeaways

Sickle cell gene therapy often comes with a lot of questions. Even when it may be an option, the cost, insurance requirements, and distance from treatment centers can make the process hard to navigate.

Coverage and costs for gene therapy can vary because these treatments are still new, and insurers and states are still working out how to cover them. Here’s what you need to know and where to find support as you explore your options.

🗳️ Have you talked with your sickle cell care team about gene therapy?
Yes, and it was helpful.
Yes, but it wasn’t helpful.
No, but I plan to.
No, and I don’t plan to.

How Much Does Sickle Cell Gene Therapy Cost?

Sickle cell gene therapy can cost millions of dollars, but the amount you pay depends on your insurance coverage, medical needs, and where you receive treatment.

Casgevy and Lyfgenia List Prices

Exagamglogene autotemcel (Casgevy) and lovotibeglogene autotemcel (Lyfgenia) are two gene therapies approved for sickle cell disease in the United States. Casgevy is approved for people ages 2 and older with recurrent pain crises, while Lyfgenia is approved for people ages 12 and older with a history of these events. Vertex Pharmaceuticals makes Casgevy, while Genetix Biotherapeutics makes Lyfgenia.

Their list prices, as reported by the Centers for Medicare & Medicaid Services (CMS), are $3.1 million for Lyfgenia and $2.2 million for Casgevy. However, these upfront costs cover the therapy itself, not necessarily what you’ll pay.

Your out-of-pocket costs will depend on several factors, including:

  • Your type of insurance and whether it covers the treatment
  • Your plan’s deductible, copays, and coinsurance
  • Whether your treatment center is in your insurance network
  • Which related services are billed separately from the therapy itself
  • Whether you qualify for financial assistance or other support

Even with insurance coverage, you may still have upfront costs and other expenses to manage. Ask your insurer what you’ll pay and which services are covered.

Costs Beyond the Therapy

Gene therapy isn’t the only cost to plan for. Other steps in treatment can add their own expenses, including:

  • Testing and evaluation — Blood work, imaging, and organ function tests help assess whether you’re eligible for treatment.
  • Stem cell collection — Collecting and preparing your cells may require multiple appointments or procedures.
  • Conditioning chemotherapy — This prepares your bone marrow for the modified cells. Side effects may require additional care and monitoring.
  • Hospitalization and recovery — You’ll spend time in the hospital and may need several months of follow-up before resuming usual activities.
  • Follow-up care — Regular blood tests and specialist visits can continue for years after treatment.

If you don’t live near a treatment center, expect travel, lodging, and meal expenses. You may also need time off work, child care, or a caregiver to stay with you.

Fertility preservation is worth discussing too. Conditioning chemotherapy can cause infertility, so ask your care team whether preserving sperm, eggs, or embryos is covered.

Does Insurance Cover Sickle Cell Gene Therapy?

Yes, in many cases. But what you pay depends on your insurance plan, eligibility, and state. Coverage can also differ between Medicaid, private insurance, and Medicare.

Medicaid Coverage and the CMS Access Model

Although Medicaid covers many people with sickle cell disease (SCD), paying for gene therapy can put added pressure on state Medicaid budgets.

The voluntary Cell and Gene Therapy (CGT) Access Model helps participating states manage the cost of gene therapy. Through this payment model, CMS negotiates agreements with manufacturers based on treatment outcomes.

If the therapy doesn’t meet certain health outcomes, participating state Medicaid programs may receive rebates from the manufacturer. Participating states also receive negotiated discounts on the therapies.

In 2026, 34 Medicaid programs are part of the model, including 32 states, Puerto Rico, and the District of Columbia. But being part of the model doesn’t mean you’ll qualify — you still need to meet its requirements and approval criteria.

The CGT Access Model also provides support for certain services for qualifying Medicaid beneficiaries. Participating manufacturers must pay for specified fertility preservation services, which are provided at no cost to people receiving gene therapy through the model.

Ask your Medicaid program or treatment center which benefits apply to you and what you’ll need to do to access them.

Private Insurance and Medicare

Private insurance and Medicare may also cover gene therapy. But coverage can vary by insurer and treatment program.

If you have private insurance or Medicare, contact your insurer to ask whether Casgevy or Lyfgenia is covered and what you’ll need to pay.

Your insurer may require the following before approving coverage:

  • Prior authorization — Your healthcare team must provide information showing that you meet the plan’s coverage requirements.
  • Medical-necessity review — The insurer may assess your medical history, previous treatments, and eligibility.
  • Specific treatment centers — Your plan may require you to use an approved or in-network treatment center.
  • Referrals — You may need a referral from your hematologist or another healthcare provider.

If the nearest qualified treatment center is outside your network or state, ask whether your plan covers out-of-network or out-of-state care. You may need approval before traveling.

Even if gene therapy is covered, you may still have deductibles, copays, or coinsurance. Ask what you’ll need to pay out of pocket.

Ask whether related services are billed separately. This can include testing, hospitalization, fertility preservation, travel, or follow-up care.

If your insurer denies coverage, ask for the denial and appeal instructions in writing. Your healthcare team may provide medical records or documentation to support your appeal.

How To Start the Process

You can start the process by talking to a hematologist. They can assess your eligibility, discuss referrals, and help you understand your insurance requirements.

Here’s what that can involve:

  • Ask for an eligibility assessment — Your hematologist can review your SCD history, previous treatments, organ function, and overall health.
  • Discuss a referral — If gene therapy is an option, ask about referral to a qualified treatment center.
  • Contact your insurance team — Ask about coverage, prior authorization, network requirements, and expected out-of-pocket costs.
  • Ask for a patient navigator or financial counselor — They can help with paperwork, financial assistance, and travel planning.
  • Plan for treatment away from home — Ask about lodging, transportation, meals, caregiving, and how long you’ll need to stay near the treatment center.

You may need support throughout treatment and long-term follow-up. Ask whether some follow-up care can happen locally to reduce trips to the treatment center.

If gene therapy isn’t an option, ask your sickle cell care team about other treatment options. These include other medications, blood transfusions, a bone marrow transplant, or a clinical trial.

The Sickle Cell Disease Association of America and its member organizations can also connect you with local resources and support.

Eligibility testing takes time. So do insurance approval and choosing a treatment center. Starting early gives you more time to prepare.

Questions To Ask Your Insurance and Healthcare Team

Before starting treatment, ask your insurer and sickle cell care team these questions:

01 Does my plan cover gene therapy, and what’s the prior authorization process?
02 Which treatment centers are in my network?
03 What out-of-pocket costs should I expect?
04 Is fertility preservation covered, or is it billed separately?
05 What financial assistance or manufacturer support programs are available?
06 What travel, lodging, or caregiver support is available?
07 What does long-term follow-up involve, and is it covered?
08 If my claim is denied, what does the appeals process look like?

Many gene therapy centers have patient navigators or social workers who can help you through the treatment process. Ask to speak with one early on.

Bringing a written list of questions to your first appointment can also help. It’s easy to forget something important once the conversation starts moving quickly.

Share this article
All updates must be accompanied by text or a picture.

We'd love to hear from you! Please share your name and email to post and read comments.

You'll also get the latest articles directly to your inbox.

Subscriber Photo Subscriber Photo Subscriber Photo
913 members
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service.
Privacy Policy • Terms of Use
All updates must be accompanied by text or a picture.

Subscribe now to ask your question, get answers, and stay up to date on the latest articles.

Get updates directly to your inbox.

Subscriber Photo Subscriber Photo Subscriber Photo
913 members
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service.
Privacy Policy • Terms of Use
Continue with Facebook
Continue with Google
By joining, you accept our Terms of Use, and acknowledge our collection, sharing, and use of your data in accordance with our Health Data and Privacy policies.
Already a member? Log In

Thank you for subscribing!

Become a member to get even more

See answer